Cite
Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial
MLA
Lei Shi, et al. “Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Lung Damage in Severe COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.” Signal Transduction and Targeted Therapy, vol. 6, no. 1, Feb. 2021, pp. 1–9. EBSCOhost, https://doi.org/10.1038/s41392-021-00488-5.
APA
Lei Shi, Hai Huang, Xuechun Lu, Xiaoyan Yan, Xiaojing Jiang, Ruonan Xu, Siyu Wang, Chao Zhang, Xin Yuan, Zhe Xu, Lei Huang, Jun-Liang Fu, Yuanyuan Li, Yu Zhang, Wei-Qi Yao, Tianyi Liu, Jinwen Song, Liangliang Sun, Fan Yang, … Fu-Sheng Wang. (2021). Effect of human umbilical cord-derived mesenchymal stem cells on lung damage in severe COVID-19 patients: a randomized, double-blind, placebo-controlled phase 2 trial. Signal Transduction and Targeted Therapy, 6(1), 1–9. https://doi.org/10.1038/s41392-021-00488-5
Chicago
Lei Shi, Hai Huang, Xuechun Lu, Xiaoyan Yan, Xiaojing Jiang, Ruonan Xu, Siyu Wang, et al. 2021. “Effect of Human Umbilical Cord-Derived Mesenchymal Stem Cells on Lung Damage in Severe COVID-19 Patients: A Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial.” Signal Transduction and Targeted Therapy 6 (1): 1–9. doi:10.1038/s41392-021-00488-5.